@article{18494,
  keywords = {Adult, Dapsone, Female, Humans, leprosy, Male, Patient Compliance},
  author = {Piscitelli S C and Danziger L H and Hill C and Slajchert A A and West D P and Fischer J H},
  title = {Effectiveness of a dapsone compliance program in leprosy.},
  abstract = {<p><b>BACKGROUND: </b>Long-term effectiveness of a dapsone compliance program was assessed in patients with leprosy.</p><p><b>METHODS: </b>The monitoring program consists of urine dapsone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty-eight patients receiving dapsone and seen in a leprosy clinic from 1985-1990 were included.</p><p><b>RESULTS: </b>The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6-year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%.</p><p><b>CONCLUSIONS: </b>Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6-year period.</p>},
  year = {1993},
  journal = {International journal of dermatology},
  volume = {32},
  pages = {206-9},
  month = {1993 Mar},
  issn = {0011-9059},
  doi = {10.1111/j.1365-4362.1993.tb02797.x},
  language = {eng},
}